Global Health Ventures, Inc. (OTC:GHLV) has announced the completion of a prototype for its latest drug, X-Excite, a male enhancement drug. The manufacture of the product was done by Vida Pharma of Montreal, Canada, under contract. Vida Pharma focused on the tablet size, taste and hardness.
Best Damn Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Stock Newsletter
Over 4,000 pills of the drug have been made with various incipient and coatings deemed safe for human consumption. The batches will be tested at the University of Columbia, Canada to be evaluated for drug absorption, taste, color, and hardness. Once the drug is approved it will be produced on a mass scale under the proprietary formula for testing in humans and applying for regulatory approval.
Sign up for the free Best Damn Penny Stocks newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website
About Us
Best Damn Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer
